Cargando…

Evaluation of Brucellosis Vaccines: A Comprehensive Review

Brucellosis is a bacterial zoonosis caused by Brucella spp. which can lead to heavy economic losses and severe human diseases. Thus, controlling brucellosis is very important. Due to humans easily gaining brucellosis from animals, animal brucellosis control programs can help the eradication of human...

Descripción completa

Detalles Bibliográficos
Autores principales: Heidary, Mohsen, Dashtbin, Shirin, Ghanavati, Roya, Mahdizade Ari, Marzie, Bostanghadiri, Narjess, Darbandi, Atieh, Navidifar, Tahereh, Talebi, Malihe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339783/
https://www.ncbi.nlm.nih.gov/pubmed/35923818
http://dx.doi.org/10.3389/fvets.2022.925773
_version_ 1784760246704537600
author Heidary, Mohsen
Dashtbin, Shirin
Ghanavati, Roya
Mahdizade Ari, Marzie
Bostanghadiri, Narjess
Darbandi, Atieh
Navidifar, Tahereh
Talebi, Malihe
author_facet Heidary, Mohsen
Dashtbin, Shirin
Ghanavati, Roya
Mahdizade Ari, Marzie
Bostanghadiri, Narjess
Darbandi, Atieh
Navidifar, Tahereh
Talebi, Malihe
author_sort Heidary, Mohsen
collection PubMed
description Brucellosis is a bacterial zoonosis caused by Brucella spp. which can lead to heavy economic losses and severe human diseases. Thus, controlling brucellosis is very important. Due to humans easily gaining brucellosis from animals, animal brucellosis control programs can help the eradication of human brucellosis. There are two popular vaccines against animal brucellosis. Live attenuated Brucella abortus strain 19 (S19 vaccine) is the first effective and most extensively used vaccine for the prevention of brucellosis in cattle. Live attenuated Brucella melitensis strain Rev.1 (Rev.1 vaccine) is the most effective vaccine against caprine and ovine brucellosis. Although these two vaccines provide good immunity for animals against brucellosis, the expense of persistent serological responses is one of the main problems of both vaccines. The advantages and limitations of Brucella vaccines, especially new vaccine candidates, have been less studied. In addition, there is an urgent need for new strategies to control and eradicate this disease. Therefore, this narrative review aims to present an updated overview of the available different types of brucellosis vaccines.
format Online
Article
Text
id pubmed-9339783
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93397832022-08-02 Evaluation of Brucellosis Vaccines: A Comprehensive Review Heidary, Mohsen Dashtbin, Shirin Ghanavati, Roya Mahdizade Ari, Marzie Bostanghadiri, Narjess Darbandi, Atieh Navidifar, Tahereh Talebi, Malihe Front Vet Sci Veterinary Science Brucellosis is a bacterial zoonosis caused by Brucella spp. which can lead to heavy economic losses and severe human diseases. Thus, controlling brucellosis is very important. Due to humans easily gaining brucellosis from animals, animal brucellosis control programs can help the eradication of human brucellosis. There are two popular vaccines against animal brucellosis. Live attenuated Brucella abortus strain 19 (S19 vaccine) is the first effective and most extensively used vaccine for the prevention of brucellosis in cattle. Live attenuated Brucella melitensis strain Rev.1 (Rev.1 vaccine) is the most effective vaccine against caprine and ovine brucellosis. Although these two vaccines provide good immunity for animals against brucellosis, the expense of persistent serological responses is one of the main problems of both vaccines. The advantages and limitations of Brucella vaccines, especially new vaccine candidates, have been less studied. In addition, there is an urgent need for new strategies to control and eradicate this disease. Therefore, this narrative review aims to present an updated overview of the available different types of brucellosis vaccines. Frontiers Media S.A. 2022-07-18 /pmc/articles/PMC9339783/ /pubmed/35923818 http://dx.doi.org/10.3389/fvets.2022.925773 Text en Copyright © 2022 Heidary, Dashtbin, Ghanavati, Mahdizade Ari, Bostanghadiri, Darbandi, Navidifar and Talebi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Veterinary Science
Heidary, Mohsen
Dashtbin, Shirin
Ghanavati, Roya
Mahdizade Ari, Marzie
Bostanghadiri, Narjess
Darbandi, Atieh
Navidifar, Tahereh
Talebi, Malihe
Evaluation of Brucellosis Vaccines: A Comprehensive Review
title Evaluation of Brucellosis Vaccines: A Comprehensive Review
title_full Evaluation of Brucellosis Vaccines: A Comprehensive Review
title_fullStr Evaluation of Brucellosis Vaccines: A Comprehensive Review
title_full_unstemmed Evaluation of Brucellosis Vaccines: A Comprehensive Review
title_short Evaluation of Brucellosis Vaccines: A Comprehensive Review
title_sort evaluation of brucellosis vaccines: a comprehensive review
topic Veterinary Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339783/
https://www.ncbi.nlm.nih.gov/pubmed/35923818
http://dx.doi.org/10.3389/fvets.2022.925773
work_keys_str_mv AT heidarymohsen evaluationofbrucellosisvaccinesacomprehensivereview
AT dashtbinshirin evaluationofbrucellosisvaccinesacomprehensivereview
AT ghanavatiroya evaluationofbrucellosisvaccinesacomprehensivereview
AT mahdizadearimarzie evaluationofbrucellosisvaccinesacomprehensivereview
AT bostanghadirinarjess evaluationofbrucellosisvaccinesacomprehensivereview
AT darbandiatieh evaluationofbrucellosisvaccinesacomprehensivereview
AT navidifartahereh evaluationofbrucellosisvaccinesacomprehensivereview
AT talebimalihe evaluationofbrucellosisvaccinesacomprehensivereview